6956-50-9Relevant articles and documents
2 - Formyl quinoline carboxamide compound and medical application thereof
-
Paragraph 0114; 0121-0126, (2021/12/07)
The invention relates to 2 - formyl quinoline carboxamide compound and medical application thereof, and the structure is shown in a formula (I). The invention further relates to a preparation method of the compound. Use of a pharmaceutical composition and
FUSED RING DERIVATIVE USED AS FGFR4 INHIBITOR
-
Paragraph 0201-0202, (2021/06/04)
A compound represented by formula I or a pharmaceutically acceptable salt thereof and a use thereof in preparing a drug for treating, stopping or preventing a disease or disorder mediated by FGFR4 activity.
FUSED PYRIMIDONES USEFUEL IN THE TREATMENT AND THE PREVENTION OF CANCER
-
Page/Page column 34, (2010/02/15)
Compounds of formula (I): which possess Eg5 inhibitory activity and are useful for their anti cell proliferation (such as anti cancer) activity and thus in methods of treatment of the human or animal body are described.
3-(2-Pyrrolidinyl)-2,4-furandione Analogs
Coppola, Gary M.,Damon, Robert E.
, p. 815 - 817 (2007/10/02)
The reaction of 4,4-dimethyl-3-oxobutanoic (or pentanoic) acid esters with the lactim ether of 2-pyrrolidone in the presence of 2-hydroxypyridine produces condensation products 4 in 57-72percent yield.Acidic hydrolysis of 4 affords the furandione system 5 in 75-81percent yield.